BRIDGEWATER, N.J., July 29,
2024 /PRNewswire/ -- Insmed Incorporated
(Nasdaq:INSM), a global biopharmaceutical company on a mission to
transform the lives of patients with serious and rare diseases,
today announced that it will release its second-quarter 2024
financial results on Thursday, August 8, 2024.
Insmed management will host a conference call for investors
beginning at 8:00 a.m. ET on Thursday,
August 8, 2024, to discuss the financial results and provide
a business update.
Shareholders and other interested parties may participate in the
conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278
(international) and referencing access code 7862189. The call will
also be webcast live on the Company's website at
www.insmed.com.
A replay of the conference call will be accessible approximately
1 hour after its completion through September 7, 2024, by dialing (800) 770-2030
(U.S.) and (609) 800-9909 (international) and referencing access
code 7862189. A webcast of the call will also be archived for 90
days under the Investor Relations section of the Company's website
at www.insmed.com.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United States, Europe,
and Japan to treat a chronic, debilitating lung disease.
The Company is progressing a robust pipeline of investigational
therapies targeting areas of serious unmet need, including
neutrophil-mediated inflammatory diseases and rare pulmonary
disorders. Insmed is also advancing an early-stage research engine
encompassing a wide range of technologies and modalities, including
artificial intelligence-driven protein engineering, gene therapy,
and protein manufacturing. Insmed is headquartered
in Bridgewater, New Jersey,
with additional offices and research locations throughout the
United States, Europe, and Japan.
Visit www.insmed.com to learn more.
Contact:
Investors:
Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com
Media:
Mandy Fahey
Vice President, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-second-quarter-2024-financial-results-conference-call-on-thursday-august-8-2024-302207872.html
SOURCE Insmed Incorporated